BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27840958)

  • 1. Suppression of LASP-1 attenuates the carcinogenesis of prostatic cancer cell lines: Key role of the NF-κB pathway.
    Sun W; Guo L; Shao G; Liu X; Guan Y; Su L; Zhao S
    Oncol Rep; 2017 Jan; 37(1):341-347. PubMed ID: 27840958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.
    Zhang H; Li Z; Chu B; Zhang F; Zhang Y; Ke F; Chen Y; Xu Y; Liu S; Zhao S; Liang H; Weng M; Wu X; Li M; Wu W; Quan Z; Liu Y; Zhang Y; Gong W
    Tumour Biol; 2016 Jun; 37(6):8305-15. PubMed ID: 26729195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma.
    Wang H; Li W; Jin X; Cui S; Zhao L
    Eur J Cancer; 2013 Mar; 49(4):974-83. PubMed ID: 23084841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway.
    Li Z; Chen Y; Wang X; Zhang H; Zhang Y; Gao Y; Weng M; Wang L; Liang H; Li M; Zhang F; Zhao S; Liu S; Cao Y; Shu Y; Bao R; Zhou J; Liu X; Yan Y; Zhen L; Dong Q; Liu Y
    Cancer Lett; 2016 Mar; 372(2):239-50. PubMed ID: 26797416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer.
    Nishikawa R; Goto Y; Sakamoto S; Chiyomaru T; Enokida H; Kojima S; Kinoshita T; Yamamoto N; Nakagawa M; Naya Y; Ichikawa T; Seki N
    Cancer Sci; 2014 Jul; 105(7):802-11. PubMed ID: 24815849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LASP-1, regulated by miR-203, promotes tumor proliferation and aggressiveness in human non-small cell lung cancer.
    Zheng J; Wang F; Lu S; Wang X
    Exp Mol Pathol; 2016 Feb; 100(1):116-24. PubMed ID: 26683818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of LIM and SH3 Protein 1 (LASP-1) Inhibits Thyroid Cancer Cell Proliferation and Invasion.
    Gao W; Han J
    Oncol Res; 2017 Jul; 25(6):879-886. PubMed ID: 27938497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of LASP-1, a novel SOX9 transcriptional target, in the progression of lung cancer.
    Shi J; Guo J; Li X
    Int J Oncol; 2018 Jan; 52(1):179-188. PubMed ID: 29138807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of LIM and SH3 Protein 1 leading to accelerated G2/M phase transition contributes to enhanced tumourigenesis in oral cancer.
    Shimizu F; Shiiba M; Ogawara K; Kimura R; Minakawa Y; Baba T; Yokota S; Nakashima D; Higo M; Kasamatsu A; Sakamoto Y; Tanzawa H; Uzawa K
    PLoS One; 2013; 8(12):e83187. PubMed ID: 24386158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytoskeletal protein LASP-1 differentially regulates migratory activities of choriocarcinoma cells.
    Segerer SE; Bartmann C; Kaspar S; Müller N; Kapp M; Butt E; Kämmerer U
    Arch Gynecol Obstet; 2016 Feb; 293(2):407-14. PubMed ID: 26232936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LIM and SH3 domain protein 1 (LASP-1) overexpression was associated with aggressive phenotype and poor prognosis in clear cell renal cell cancer.
    Yang F; Zhou X; Du S; Zhao Y; Ren W; Deng Q; Wang F; Yuan J
    PLoS One; 2014; 9(6):e100557. PubMed ID: 24955835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1.
    Zhao L; Wang H; Liu C; Liu Y; Wang X; Wang S; Sun X; Li J; Deng Y; Jiang Y; Ding Y
    Gut; 2010 Sep; 59(9):1226-35. PubMed ID: 20660701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation.
    Grunewald TG; Kammerer U; Winkler C; Schindler D; Sickmann A; Honig A; Butt E
    Br J Cancer; 2007 Jan; 96(2):296-305. PubMed ID: 17211471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Livin mediates tumor cell invasion in the DU-145 cell line via NF-κB.
    Chen F; Yang D; Che X; Wang J; Li X; Zhang Z; Chen X; Song X
    Oncol Rep; 2012 Jun; 27(6):2010-6. PubMed ID: 22427141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex.
    Duvall-Noelle N; Karwandyar A; Richmond A; Raman D
    Oncogene; 2016 Mar; 35(9):1122-33. PubMed ID: 25982273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of LASP-1 expression reveals vimentin as its new partner in human hepatocellular carcinoma cells.
    Salvi A; Bongarzone I; Ferrari L; Abeni E; Arici B; De Bortoli M; Scuri S; Bonini D; Grossi I; Benetti A; Baiocchi G; Portolani N; De Petro G
    Int J Oncol; 2015 May; 46(5):1901-12. PubMed ID: 25760690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LASP-1, a novel urinary marker for detection of bladder cancer.
    Ardelt P; Grünemay N; Strehl A; Jilg C; Miernik A; Kneitz B; Butt E
    Urol Oncol; 2013 Nov; 31(8):1591-8. PubMed ID: 22481019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration.
    Hailer A; Grunewald TG; Orth M; Reiss C; Kneitz B; Spahn M; Butt E
    Oncotarget; 2014 Jun; 5(12):4144-4153. PubMed ID: 24980827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
    Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact of LASP-1 expression on proliferation and tumorigenesis of human colorectal cancer cell line SW480].
    Zhao L; Ding YQ
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):830-4. PubMed ID: 21215099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.